£50k
−8%vs Jun 2024Active07516226Private limited companyCambridge
CAMBIMUNE LIMITED
Significant control: Grant Craig Austin (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Cambimune Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Cambimune Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
CAMBIMUNE LIMITED is an active private limited company (company number 07516226) incorporated on 3 February 2011, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 June 2025, showing net assets of £50k and cash of £21k, with 0 employees on average. Net assets fell 8% on the prior period (£54k).
Peer position · net assets
By net assets it sits in the upper half of 196 comparable companies in Cambridge (median £15k, upper quartile £347k).
02
Ownership and control
- Mr Grant Craig Austin
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Dr Albert Philip Adrian Mockett
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 3 February 201115 yrs ago
- Next accounts due
- 30 March 2027in 155 days
- Confirmation statement due
- 17 February 2027in 114 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£21k
+5087%vs Jun 2024Not reported
0
vs Jun 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | £50k | £21k | £593 | — | — | — | 0 |
| 30 June 2024 | £54k | £398 | £3,398 | — | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £49,986 at 30 June 2025
- Incorporated five or more years agoIncorporated 3 February 2011
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 155 days
- Confirmation statement duein 114 days
- Accounts period endNet assets £50k · small accounts
- Accounts period endNet assets £54k · small accounts
- Incorporated
08
Similar companies in Cambridge
- NEWMARKET BIOMEDICAL LIMITEDKentford · inc. Jan 2011
- JOHN MCNAMARA CONSULTING LIMITEDCambridge · inc. Dec 2010
- PIXL BIO LTDCambridge · inc. Apr 2011
- DIAGNODUS LTDCambridge · inc. Apr 2011
- MISSION THERAPEUTICS LIMITEDCambridge · inc. May 2011
- LYCOTEC LIMITEDCambridge · inc. Oct 2010
All companies incorporated on 3 February 2011 · in Feb 2011.
09
Reminders for CAMBIMUNE LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.